Heidelberg Engineering GmbH has received U.S. Food and Drug Administration (FDA) clearance for the company’s pioneering SL-OCT(TM) product, the world’s first commercial optical coherence tomography (OCT) device used for cross-sectional anterior segment imaging. The SL-OCT was first introduced in Europe, receiving CE mark certification in 2003.
The device is innovative in two ways: Not only is it the first commercial application of OCT for anterior segment imaging, but its mounting on a slit lamp offers users both space savings and cost advantages. The SL-OCT provides easy-to-use, noncontact cross-sectional scans of the anterior segment. Chamber angle, pachymetry, flap thickness, corneal curvature and comprehensive biometric measurements are possible with the instrument, as well as pre- and post-surgical comparisons.